Cellectis S.A. (CLLS)

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of $155.56 million. The enterprise value is $90.91 million.

Market Cap	155.56M
Enterprise Value	90.91M

Important Dates

The last earnings date was Monday, November 4, 2024, after market close.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 100.09 million shares outstanding. The number of shares has increased by 57.15% in one year.

Current Share Class	n/a
Shares Outstanding	100.09M
Shares Change (YoY)	+57.15%
Shares Change (QoQ)	+11.40%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	71.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	2.96
PB Ratio	n/a
P/TBV Ratio	1.21
P/FCF Ratio	2.57
P/OCF Ratio	2.48
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1.50

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.69.

Current Ratio	1.78
Quick Ratio	1.13
Debt / Equity	0.69
Debt / EBITDA	n/a
Debt / FCF	1.49
Interest Coverage	-10.99

Financial Efficiency

Return on equity (ROE) is -82.20% and return on invested capital (ROIC) is -25.71%.

Return on Equity (ROE)	-82.20%
Return on Assets (ROA)	-16.09%
Return on Capital (ROIC)	-25.71%
Revenue Per Employee	$163,086
Profits Per Employee	-$382,253
Employee Count	221
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-508,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.04% in the last 52 weeks. The beta is 3.20, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.20
52-Week Price Change	-51.04%
50-Day Moving Average	1.88
200-Day Moving Average	2.26
Relative Strength Index (RSI)	34.53
Average Volume (20 Days)	59,760

Short Selling Information

Short Interest	131,398
Short Previous Month	140,456
Short % of Shares Out	0.16%
Short % of Float	n/a
Short Ratio (days to cover)	1.41

Income Statement

In the last 12 months, Cellectis had revenue of $36.04 million and -$84.48 million in losses. Loss per share was -$1.04.

Revenue	36.04M
Gross Profit	35.31M
Operating Income	-77.95M
Pretax Income	-80.31M
Net Income	-84.48M
EBITDA	-67.22M
EBIT	-77.95M
Loss Per Share	-$1.04

Balance Sheet

The company has $159.09 million in cash and $89.87 million in debt, giving a net cash position of $69.22 million or $0.69 per share.

Cash & Cash Equivalents	159.09M
Total Debt	89.87M
Net Cash	69.22M
Net Cash Per Share	$0.69
Equity (Book Value)	129.42M
Book Value Per Share	1.29
Working Capital	128.78M

Cash Flow

In the last 12 months, operating cash flow was $62.75 million and capital expenditures -$2.31 million, giving a free cash flow of $60.44 million.

Operating Cash Flow	62.75M
Capital Expenditures	-2.31M
Free Cash Flow	60.44M
FCF Per Share	$0.60

Margins

Gross margin is 97.96%, with operating and profit margins of -216.28% and -234.39%.

Gross Margin	97.96%
Operating Margin	-216.28%
Pretax Margin	-235.80%
Profit Margin	-234.39%
EBITDA Margin	-186.49%
EBIT Margin	-216.28%
FCF Margin	167.70%

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.15%
Shareholder Yield	-57.15%
Earnings Yield	-54.30%
FCF Yield	38.86%

Analyst Forecast

The average price target for Cellectis is $7.00, which is 326.83% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	326.83%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	62.07%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -1.32 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.32
Piotroski F-Score	4